NFL Biosciences Receives European Patent Approval for NFL-101 and EMA Approval for Clinical Development Plan NFL Biosciences Receives European Patent Approval for NFL-101 and EMA Approval for Clinical Development Plan Read the full IIPLA article: https://iipla.org/news/nfl-biosciences-receives-european-patent-approval-for-nfl-101-and-ema-approval-for-clinical-development-plan
IIPLA appoints Michael Dryja as its United States Representative to support conference activities and engagement with the U.S. intellectual property community.
‘Purple Rain’ Co-Star Ends ‘Apollonia’ Trademark Rights Suit By Editorial Team Patty Apollonia Kotero, known for her role as Prince’s co-star in the iconic 1984 film “Purple Rain,” has decided to drop her lawsuit agai...
An Irish patent owner, Valtrus Innovations Ltd., has filed a lawsuit against Vertiv Corp.'s data center customers, alleging patent infr...
Dish Network LLC has emerged victorious in a copyright infringement lawsuit against a Florida businessman for streaming...
A Houston-based patent attorney faced a tough Federal Circuit bench while seeking to wipe out a $207,000 sanction against him and his clie...
A subsidiary of Johnson & Johnson has successfully defended its patent for a hemostatic powder used to treat bleeding against objections from B...